Table of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	29
2.4 Emerging Opportunities and Market Trends	32
2.5 Porter’s Fiver Forces Analysis	36
3 Segmentation of North America Market by Virus Type	40
3.1 Market Overview by Virus Type	40
3.2 HSV-1	42
3.3 HSV-2	43
4 Segmentation of North America Market by Drug Type	44
4.1 Market Overview by Drug Type	44
4.2 Acyclovir	47
4.3 Valacyclovir	48
4.4 Famciclovir	49
4.5 Other Drugs	50
5 Segmentation of North America Market by Route of Administration	52
5.1 Market Overview by Route of Administration	52
5.2 Oral	54
5.3 Topical	55
5.4 Injection	56
6 Segmentation of North America Market by Patient Gender	57
6.1 Market Overview by Patient Gender	57
6.2 Female	59
6.3 Male	60
7 Segmentation of North America Market by Distribution Channel	61
7.1 Market Overview by Distribution Channel	61
7.2 Retail Pharmacies	63
7.3 Hospital Pharmacies	64
7.4 Online Pharmacies	65
7.5 Drug Stores	66
8 North America Market 2022-2032 by Country	67
8.1 Overview of North America Market	67
8.2 U.S.	70
8.3 Canada	75
8.4 Mexico	77
9 Competitive Landscape	79
9.1 Overview of Key Vendors	79
9.2 New Product Launch, Partnership, Investment, and M&A	82
9.3 Company Profiles	83
Abbott	83
ADLEY FORMULATIONS	85
Aurobindo Pharma Ltd.	86
Avet Pharmaceuticals Inc.	87
Bausch Health Companies	88
Centurion Remedies	89
Cipla Ltd.	90
Eli Lilly & Company	91
Finecure Pharmaceuticals	92
GlaxoSmithKline Plc	93
Glenmark Pharmaceuticals	94
Macleods Pharmaceuticals	95
Medico Remedies	96
Merck & Co., Inc.	97
Novartis AG	98
Pfizer	99
Reddy's Laboratories	100
Sanofi SA	101
Teva Pharmaceutical Industries Ltd.	102
Torrent Pharma	103
Viatris Inc.	104
Zeelab Pharmacy	105
Zydus Pharmaceuticals, Inc.	106
RELATED REPORTS	107

List of Tables:

Table 1.  Snapshot of North America Genital Herpes Treatment Market in Balanced Perspective, 2022-2032	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	28
Table 5.  Main Product Trends and Market Opportunities in North America Genital Herpes Treatment Market	32
Table 6. North America Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	40
Table 7. North America Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	44
Table 8. Side Effects of Genital Herpes Medications	44
Table 9. Vaccine Pipelines for Herpes	51
Table 10. North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn	52
Table 11. North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn	57
Table 12. North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	61
Table 13. North America Genital Herpes Treatment Market by Country, 2022-2032, $ mn	68
Table 14. U.S. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	74
Table 15. U.S. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	74
Table 16. U.S. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	74
Table 17. Canada Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	76
Table 18. Canada Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	76
Table 19. Canada Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	76
Table 20. Mexico Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	78
Table 21. Mexico Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	78
Table 22. Mexico Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	78
Table 23. Abbott: Company Snapshot	83
Table 24. Abbott: Business Segmentation	84
Table 25. Abbott: Product Portfolio	84

List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032	16
Figure 4. North America Genital Herpes Treatment Market, 2022-2032, $ mn	19
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of North America Genital Herpes Treatment Market	25
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million	28
Figure 8. Primary Restraints and Impact Factors of North America Genital Herpes Treatment Market	29
Figure 9. Investment Opportunity Analysis	33
Figure 10. Porter’s Fiver Forces Analysis of North America Genital Herpes Treatment Market	36
Figure 11. Breakdown of North America Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue	41
Figure 12. North America Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)	41
Figure 13. North America Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn	42
Figure 14. North America Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn	43
Figure 15. Breakdown of North America Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue	45
Figure 16. North America Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)	45
Figure 17. North America Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn	47
Figure 18. North America Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn	48
Figure 19. North America Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn	49
Figure 20. North America Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn	50
Figure 21. Breakdown of North America Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue	53
Figure 22. North America Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)	53
Figure 23. North America Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn	54
Figure 24. North America Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn	55
Figure 25. North America Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn	56
Figure 26. Breakdown of North America Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue	58
Figure 27. North America Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)	58
Figure 28. North America Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn	59
Figure 29. North America Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn	60
Figure 30. Breakdown of North America Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue	62
Figure 31. North America Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)	62
Figure 32. North America Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn	63
Figure 33. North America Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn	64
Figure 34. North America Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn	65
Figure 35. North America Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn	66
Figure 36. Breakdown of North America Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	68
Figure 37. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	69
Figure 38. Percentage of LGBT in Total Population in U.S., 2012-2021	71
Figure 39. Estimated Number of New (Incident) and Existing (Prevalent) Sexually Transmitted Infections in U.S. in 2018	72
Figure 40. Healthcare Cost by STI Type in U.S. in 2018	73
Figure 41. U.S. Genital Herpes Treatment Market, 2022-2032, $ mn	73
Figure 42. Canada Genital Herpes Treatment Market, 2022-2032, $ mn	75
Figure 43.  Genital Herpes Treatment Market in Mexico, 2022-2032, $ mn	77
Figure 44. Growth Stage of North America Genital Herpes Treatment Industry over the Forecast Period	79

Selected Key Players: 
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)